Sun Diagnostics
Stage
Unattributed | AliveTotal Raised
$50KLast Raised
$50K | 9 yrs agoAbout Sun Diagnostics
Sun Diagnostics strives to identify and develop new products for the in vitro diagnostic (IVD) industry that will contribute to the advancement of laboratory medicine and improve healthcare. The company's focus is on innovative products that meet the needs of patients, clinicians, laboratories, and researchers.
Missing: Sun Diagnostics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Sun Diagnostics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Sun Diagnostics News
Sep 30, 2014
Testing for reproductive interference in the population dynamics of two congeneric species of herbivorous mites Manufacturers and clinical laboratories are doing a reasonably good job assessing endogenous interferents that may alter lab test results. The next big hurdle is the assessment of interference from common drugs. There are literally hundreds of drugs in clinical use, both prescription and over-the-counter, which can vary widely in their blood and urine concentrations and which can introduce errors in laboratory testing. Which are the most important to test? An expert panel was convened to make specific recommendations concerning the drugs and concentrations that should be assessed when validating laboratory tests.1 Preparing concentrated drug solutions for interference testing has been labor intensive and expensive - until now. Sun Diagnostics now offers ASSURANCE™ DRUG Interference Test Kit for Laboratory Use as part of interference testing procedures. Interferents available include: ACETAMINOPHEN, N-ACETYLCYSTEINE, ACETYLSALICYLIC ACID, AMPICILLIN SODIUM, CEFOXITIN SODIUM, CYCLOSPORINE, DOXYCYCLINE HCL, HEPARIN, IBUPROFEN, LEVODOPA, METHYLDOPA, METRONIDAZOLE, PHENYLBUTAZONE, RIFAMPICIN, and THEOPHYLLINE. Components may be purchased individually, in customer-defined combinations, or as INT-04 (one vial of each component). Drug components and concentrations are based on recommendations by the expert panel1 and the Clinical Laboratory Standards Institute (CLSI).2 The concentrations are 20 times the recommended test concentrations, allowing a 1:20 dilution with serum/urine pool. Drugs included are acetylcysteine, ampicillin Na, cefoxitin Na, doxycycline HCl, theophylline, levodopa, methyldopa, metronidazole, acetylsalicylic acid, ibuprofen, phenylbutazone, rifampicin, cyclosporine, acetaminophen and heparin, all at 20X concentrations.
Sun Diagnostics Frequently Asked Questions (FAQ)
Where is Sun Diagnostics's headquarters?
Sun Diagnostics's headquarters is located at 60 Pineland Drive, New Gloucester.
What is Sun Diagnostics's latest funding round?
Sun Diagnostics's latest funding round is Unattributed.
How much did Sun Diagnostics raise?
Sun Diagnostics raised a total of $50K.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.